%A Yao Yang, Jia Yingjie, Deng Renfen, Li Xiaojiang, Kong Fanming %T Maintenance treatment for advanced gastric cancer %0 Journal Article %D 2019 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2019.07.011 %P 439-442 %V 46 %N 7 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_10673.shtml} %8 2019-07-08 %X S-1 and capecitabine are relatively ideal agents for maintenance treatment of advanced gastric cancer. In clinical trials of using immune and targeted drugs for maintenance treatment of advanced gastric cancer, ipilimumab fails to obtain positive results, ramucirumab has not obtained research data, and trial regimens of maintenance treatment with trastuzumab, bevacizumab and avelumab have all shown initial efficacy. Traditional Chinese medicine therapy has shown some effectiveness in maintenance treatment, which still needs further researches.